당뇨병성 족부질환자의 직접의료비용 분석

Analysis of Direct Service Costs about Diabetic Foot Patients

  • 송종례 (아주대학교병원 가정간호센터) ;
  • 이진우 (연세대학교 의과대학 정형외과학교실) ;
  • 한승환 (아주대학교 의과대학 정형외과학교실)
  • Song, Chong-Rye (Home Care Services Center, Ajou University Hospital) ;
  • Lee, Jin-Woo (Department of Orthopedic Surgery, Yonsei University College of Medicine) ;
  • Han, Seung-Hwan (Department of Orthopedic Surgery, Ajou University School of Medicine)
  • 투고 : 2011.07.30
  • 심사 : 2011.08.16
  • 발행 : 2011.09.15

초록

Purpose: The objective of this study was to analyze diabetic foot patients' direct service costs until the cure of the disease. Materials Methods: The subjects of this study were randomly sampled 60 patients who had been treated for diabetic foot at one of two tertiary hospitals and cured of the disease during from January 2008 to December 2009, and whose diagnostic code was E11.5 or E14.5. Data were collected from medical records and direct service costs were analyzed using data on the payments of individual service charges. Direct service costs spent at other medical institutions for the same disease were excluded. Collected data were analyzed using descriptive statistics. Results: The subjects' mean hospital stay was 29 days, and mean period until cure was 132 days. The inpatient cost per patient was 10,844,648 won, outpatient cost was 715,751 won, and home care services cost was 641,854 won, so total direct service cost per patient was 11,913,419 won. The total direct service cost in patients who had their foot amputated was 12,769,822 won, 1.3 times higher than without amputation, who had vascular intervention was 16,219,477 won, 1.9 times higher than non-vascular intervention, who had both infection and artery occlusion was 17,522,435 won, 2.0 times higher than either infection or artery occlusion. Conclusion: In diabetic foot patients, the direct service cost was highest as 17,522,435 won in patients accompanied with both infection and occlusion of lower extremity artery.

키워드

참고문헌

  1. OECD Korea Policy Centre. Health at a Glance 2009: OECD INDICATORS, OECD Korea Policy Centre Health and Social Policy Programme. 2010. 200.
  2. Basic Statistics Diabetes Task Force Team. Basic statistics on diabetes Task Force Team report: Diabetes in Korea 2007. Korean Diabetes Association & Health Insurance Review & Assessment Service 2007. 74.
  3. Chung CH, Kim DJ, Kim JY, et al. Current status of diabetic foot in Korean patients using national health insurance database. J Korean Diabetes Assoc. 2006;30:372-6. https://doi.org/10.4093/jkda.2006.30.5.372
  4. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366: 1719-24. https://doi.org/10.1016/S0140-6736(05)67698-2
  5. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev. 2000;16 Suppl 1:S75-83. https://doi.org/10.1002/1520-7560(200009/10)16:1+<::AID-DMRR139>3.0.CO;2-8
  6. Hwang JA, Park TC, Jung SH, et al. Direct medical costs of type 2 diabetic patients in the tertiary hospital. Korean Diabetes J. 2008;32:259-68. https://doi.org/10.4093/kdj.2008.32.3.259
  7. Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998;20:169-81. https://doi.org/10.1016/S0149-2918(98)80044-1
  8. Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower- extremity ulcers among patients with diabetes. Diabetes Care. 2004;27:2129-34. https://doi.org/10.2337/diacare.27.9.2129
  9. Korea Hospital Association. National Insurance Claim Guide Book. 2010. 688.
  10. Park IB, Kim DJ, Kim JY, et al. - The report of epidemiological study for diabetic diseases- focus on "Diabetes in Korea 2007". Clinical Diabetes. 2007;8:356-60.